In July, we added 127 citations in DIDB, including 70 in vitro (with 17 articles published in July 2024) and 57 in vivo articles (with 41 articles published in July 2024).
4 NDA/BLAs approved in 2024, including crovalimab (PIASKY), imetelstat (RYTELO), sofpironium (SOFDRA), and tarlatamab (IMDELLTRA), were also curated in DIDB.
You can check the citations that are recently published and entered in DIDB and all the NDAs/BLAs in DIDB.
As always, feel free to contact us if you have any questions or comments.